Skip to Content
Merck
CN
  • Multi-targeted therapy resistance via drug-induced secretome fucosylation.

Multi-targeted therapy resistance via drug-induced secretome fucosylation.

eLife (2023)
Aldonza, et al.
MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
PNGase F from Elizabethkingia meningoseptica, BioReagent, ≥95% (SDS-PAGE)
Sigma-Aldrich
Anti-von Willebrand Factor Antibody, Chemicon®, from rabbit